LINDE PLC (LIN)
Industrial Inorganic Chemicals · Healthcare · $263.6B
Intrinsic Value (Consensus)
$165.93
Current Price
$518.17
Margin of Safety
-68%
68% Above Intrinsic Value
Value: $166
Price: $518
Valuation Model Estimates
Current Price: $518.17
DCF (Discounted Cash Flow)
$185.60
Graham Number
$157.21
Earnings Power Value
$141.84
Relative Value (P/E)
$292.20
Dividend Discount Model
$52.78
Consensus Value
$165.93
Model Assumptions
Discount Rate
10.3%
Growth Rate
7.3%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
61
Profitability
22/25
Strength
22/25
Valuation
7/25
Growth
10/25
Key Financials
- EPS (TTM)
- $14.61
- EPS (Forward)
- $15.67
- Book Value
- $75.18
- P/E Ratio
- 20.0
- Forward P/E
- 18.6
- PEG Ratio
- —
- ROE
- 18.0%
- Debt/Equity
- 59%
- Revenue Growth
- 3.0%
- Earnings Growth
- 7.3%
- Dividend Yield
- 0.5%
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance